Evidence map›Paper›PMID 34359378›Full record

ArticleDiagnostics (Basel, Switzerland)2021

Evaluation of Integrin α

Kosuke Mitsuyuki, Tadashi Watabe, Sadahiro Naka, Yuwei Liu, Mitsuaki Tatsumi, Eku Shimosegawa, Hiroki Kato

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Diagnostics (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.4field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Current trends in the characterization and monitoring of vascular response to cancer therapy.Cancer imaging : the official publication of the International Cancer Imaging Society · 2024
    Review
  2. Review
  3. Clinical Evaluation ofJournal of nuclear medicine : official publication, Society of Nuclear Medicine · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Kosuke MitsuyukiDepartment of Nuclear Medicine and Tracer Kinetics, Graduate School of Medicine, Osaka University, Suita 565-0871, Japan.ORCID 0000-0001-7640-2186
Tadashi WatabeDepartment of Nuclear Medicine and Tracer Kinetics, Graduate School of Medicine, Osaka University, Suita 565-0871, Japan.ORCID 0000-0001-8658-2395
Sadahiro NakaDepartment of Radiology, Osaka University Hospital, Suita 565-0871, Japan.
Yuwei LiuDepartment of Nuclear Medicine and Tracer Kinetics, Graduate School of Medicine, Osaka University, Suita 565-0871, Japan.
Mitsuaki TatsumiDepartment of Radiology, Osaka University Hospital, Suita 565-0871, Japan.
Eku ShimosegawaDepartment of Molecular Imaging in Medicine, Graduate School of Medicine, Osaka University, Suita 565-0871, Japan.
Hiroki KatoDepartment of Nuclear Medicine and Tracer Kinetics, Graduate School of Medicine, Osaka University, Suita 565-0871, Japan.ORCID 0000-0003-0838-6772
The University of Osaka · JPOsaka University Hospital · JP

Funding

Japan Science and Technology Agency JPMJOP1721
6 · The paper itself

Abstract

Tumor blood flow (TBF) is related to drug delivery and hypoxia, both of which can impact the efficacy of anti-cancer therapies. Although integrin α

Indexed as

[68Ga]Ga-DOTA-c(RGDfK)C6 gliomaMIA PaCa-2small-animal positron emission tomographytumor angiogenesistumor blood flow

Identifiers

PMID34359378
PMCPMC8307120
OpenAlexW3184227689

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.